Search Results for "f"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for f. Results 331 to 340 of 864 total matches.
CT Colonography (Virtual Colonoscopy) Revisited
The Medical Letter on Drugs and Therapeutics • Dec 01, 2008 (Issue 1300)
. Roden, M.D., Vanderbilt University School of Medicine
F. Estelle R. Simons, M.D., University ...
Options in screening for colon cancer include fecal occult blood tests, flexible sigmoidoscopy, colonoscopy, computed tomography (CT) colonography and fecal DNA tests. Since the last Medical Letter article on this subject, more data have become available on colonography.
CRP and Statins for Primary Prevention of Coronary Artery Disease
The Medical Letter on Drugs and Therapeutics • Dec 15, 2008 (Issue 1301)
., University Hospital, Copenhagen
Dan M. Roden, M.D., Vanderbilt University School of Medicine
F. Estelle R ...
Modestly elevated C-reactive protein (CRP) concentrations have been associated with an increased risk of coronary heart disease. The recently published and heavily publicized results of the JUPITER trial will lead many patients to ask health care professionals whether they should have a CRP test to see if they should be taking a statin.
A Granisetron Patch (Sancuso)
The Medical Letter on Drugs and Therapeutics • Dec 15, 2008 (Issue 1301)
School of Medicine
F. Estelle R. Simons, M.D., University of Manitoba
Neal H. Steigbigel, M.D., New ...
The treatment of choice to prevent emesis due to highand moderate-risk emetogenic drugs used in cancer chemotherapy is aprepitant plus a serotonin receptor antagonist plus dexamethasone. Four serotonin receptor antagonists are available in the US in intravenous (IV) formulations for prevention of nausea and vomiting due to cancer chemotherapy, and 3 of these are also available for oral use. Now the FDA has approved one of these, granisetron, in a transdermal formulation (Sancuso - ProStrakan).
Dolutegravir (Tivicay) for HIV
The Medical Letter on Drugs and Therapeutics • Sep 30, 2013 (Issue 1426)
. F Raffi et al. Lancet 2013; 381:735.
2. S Walmsley et al. Presented at 52nd Interscience Conference ...
The FDA has approved dolutegravir (doll-you-TEG-rah-veer;
Tivicay – Viiv Healthcare), an integrase strand
transfer inhibitor (INSTI), for treatment of HIV-1 infection
in adults and in children ≥12 years old who weigh at least 40 kg. It is the third INSTI to be approved by the FDA; raltegravir
and elvitegravir were approved earlier.
An Imaging Agent for Amyloid
The Medical Letter on Drugs and Therapeutics • Jul 09, 2012 (Issue 1394)
of amyloid deposition in
Alzheimer disease using radioligand 18F-AV-45 (florbetapir F
18). J Nucl Med 2010 ...
The FDA has approved florbetapir F18 (flor bay´ ta pir;
Amyvid – Lilly), an intravenous radioactive diagnostic
agent used with positron emission tomography (PET)
scans, to estimate β-amyloid neuritic plaque density in
adults being evaluated for Alzheimer's disease (AD) or
other causes of cognitive decline.
Drug Interaction: Dabigatran (Pradaxa) and Statins
The Medical Letter on Drugs and Therapeutics • Jan 30, 2017 (Issue 1513)
, atenolol, celecoxib and cimetidine.
Int J Clin Pharmacol Ther 2005; 43:527.
7. F Violi et al. Statins ...
The results of a recently published study suggest that
taking the oral direct thrombin inhibitor dabigatran
etexilate (Pradaxa) with either simvastatin (Zocor, and
others) or lovastatin (Altoprev, and others) increases the
risk of major hemorrhage.
In Brief: Expanded Indication for Elevidys
The Medical Letter on Drugs and Therapeutics • Aug 19, 2024 (Issue 1709)
. Med Lett Drugs Ther 2023; 65:159.
2. F Muntoni et al. ENVISION, a phase 3, randomized trial ...
The adeno-associated virus (AAV) vector-based
gene therapy delandistrogene moxeparvovec-rokl
(Elevidys – Sarepta) received accelerated approval
from the FDA in 2023 for treatment of ambulatory
children 4-5 years old with Duchenne muscular
dystrophy (DMD) who have a confirmed mutation
in the DMD gene. It has now received full approval
for use in ambulatory patients ≥4 years old and
accelerated approval for use in nonambulatory
patients with DMD.
Med Lett Drugs Ther. 2024 Aug 19;66(1709):135-6 doi:10.58347/tml.2024.1709e | Show Introduction Hide Introduction
Substituting For Troglitazone
The Medical Letter on Drugs and Therapeutics • Apr 17, 2000 (Issue 1076)
of Medicine; F. Estelle R. Simons, M.D., University of Manitoba EDITORIAL FELLOWS: Richard Kim, M.D ...
Full-page advertisements in newspapers are urging patients with type 2 diabetes coming off Rezulin to ask their doctors to switch to Avandia or Actos. Troglitazone was withdrawn from the market on March 21 because of rare but severe hepatic toxicity.
Cosmetic Phalloplasty
The Medical Letter on Drugs and Therapeutics • May 24, 2004 (Issue 1183)
, M.D.,
University Hospital, Copenhagen; Dan M. Roden, M.D., Vanderbilt School of Medicine; F. Estelle ...
Some patients may be asking healthcare providers about the surgical techniques to enlarge the penis that are widely promoted on the Internet. Phalloplasty was first used to treat traumatic or surgical amputation (for cancer), epispadias and Peyronie's disease (JP Yurkanin et al, J Urol 2001; 166:1769).
Pantroprazole (Protonix)
The Medical Letter on Drugs and Therapeutics • Jul 24, 2000 (Issue 1083)
., University Hospital, Copenhagen; Dan M. Roden, M.D., Vanderbilt School of Medicine; F. Estelle R. Simons, M.D ...
Pantoprazole, the fourth benzimidazole proton pump inhibitor to become available in the United States, has been marketed for short-term oral treatment of erosive gastroesophageal reflux disease (GERD).